NURSING ASSESSMENT OF PRESSURE SORE RISK

压疮风险的护理评估

• 批准号: 3391078
• 负责人: NANCY I. BERGSTROM
• 金额: $ 36.48万
• 依托单位: UNIVERSITY OF NEBRASKA MEDICAL CENTER
• 依托单位国家: 美国
• 财政年份: 1984
• 资助国家: 美国
• 起止时间: 1984-09-28 至 1994-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3391078
• 关键词: blood chemistry; caloric dietary content; decubitus ulcer; diagnosis design /evaluation; dietary calcium; dietary carbohydrates; dietary constituent; dietary iron; dietary lipid; dietary mineral; dietary proteins; dietary trace element; dietetics; disease /disorder proneness /risk; extended care; geriatric nursing; home health care; hospital patient care; human old age (65+); human subject; niacin; nurses; nursing diagnosis; nursing homes; nursing intervention; nursing research; nutrition disorder diagnosis; nutrition related tag; retinoids; riboflavin; skin disorder diagnosis; thiamine; vitamin D; water drinking behavior

The specific aim of this study is to establish the validity of the Braden Scale for Predicting Pressure Sore (PA) Risk. More specifically, the study aims for the first phase of the study are to (a) identify the critical cut-off score at which risk is accurately predicted, (b) determine the misclassification rate of the critical cut-off score, (c) determine the influence of age, sex, race, diagnosis and other factors on the predictive validity of the Braden Scale, (d) identify the frequency of reassessment necessary to accurately predict changes in PS risk among inpatients and home health care patients, and (e) compare the predictive validity of the Braden Scale in home health care practice versus inpatient acute and long-term care settings. In a second phase, the risk classification accuracy of the scale will be tested in a new population. The study will be conducted in four acute care hospitals, three nursing homes, and two home health agencies. The same prospective design will be used in each setting. Subjects meeting the following criteria will be randomly selected from each setting: (a) PS free on admission to the study, (b) expected length of hospital/institutional stay at least ten days or expected duration of home care of one month, (c) home care patients are home bound, and (d) subjects agree to participate. PS risk will be assessed using the Braden Scale, and demographic data will be recorded from patient records or by interviewing the patient. A nurse who will remain blind to the risk assessment score will systematically assess skin condition. Inpatients will be studied by assessing risk and skin condition three times per week for a maximum of four weeks or until discharge from the institution. Home care patients will be studied through weekly assessments for a maximum of four weeks. Preventing PS is undoubtedly less costly than treatment, but prevention is also expensive. Protective devices such as special beds may cost $85/day or more. Accurate prediction of risk will permit preventive treatments and devices to be ordered in a timely manner for patients at risk while reducing the unnecessary and costly treatment of persons who are not at risk for developing PS.

这项研究的具体目的是建立 预测压疮(PA)风险的Braden评分。更多 具体地说，第一阶段研究的目的是 (A)确定风险准确达到的临界点分数 预测，(B)确定关键数据的误分率 分界值，(C)确定年龄、性别、种族、 诊断和其他因素对预测效度的影响 Braden量表，(D)确定重新评估的频率 需要准确预测以下人群中PS风险的变化 住院病人和家庭保健病人，以及(五)比较 Braden量表在家庭保健中的预测效度 实践与住院急性和长期护理环境的对比。在一个 第二阶段，量表的风险分类准确率将为 在新的人群中进行了测试。这项研究将分四个阶段进行 急性护理医院、三家疗养院和两家家庭健康中心 经纪公司。每个项目都将使用相同的预期设计 布景。符合以下标准的受试者将被随机 从每个环境中选择：(A)进入研究时不含PS， (B)预计住院/住院时间至少为10天 或家庭护理的预期期限为一个月，(C)家庭护理 患者被困在家中，(D)受试者同意参与。PS 风险将使用Braden量表和人口统计数据进行评估 将从患者记录中记录下来，或通过采访 有耐心的。对风险评估视而不见的护士 SCORE将系统地评估皮肤状况。住院病人将会是 通过每周三次评估风险和皮肤状况进行研究 最多四周或直到出院为止 机构。家庭护理患者将通过每周的研究 评估时间最长为四周。预防PS是 无疑比治疗成本更低，但预防也是 很贵的。保护设备，如特殊的床，可能会花费 85美元/天或更多。对风险的准确预测将使 应及时订购预防性治疗和设备 对有风险的患者的态度，同时减少不必要的和 对没有发生PS风险的人进行昂贵的治疗。

项目成果

A program design to reduce chronic readmissions for pressure sores.

一项旨在减少慢性压疮再次入院的计划。

• DOI: 10.1002/j.2048-7940.1987.tb00544.x
• 发表时间: 1987
• 期刊: Rehabilitation nursing : the official journal of the Association of Rehabilitation Nurses
• 作者: LaMantia,JG;Hirschwald,JF;Goodman,CL;Wooden,VM;Delisser,O;StaasJr,WE
• 通讯作者: StaasJr,WE